Table 2

Optimal laboratory measurements associated with lowest risk of microvascular complication

	n	A1C		LDL-C		SBP		DBP
	n	Estimate	SD	Estimate	SD	Estimate	SD	Estimate	SD
Whole population	124 651	6.81	0.32	109.10	12.03	Positive linear		Negative linear
Subgroup
Age
<50	15 819	Positive linear		105.78	20.31	Positive linear		Negative linear
(50, 60)	36 539	6.88	0.35	98.90	10.85	Positive linear		Negative linear
(60, 70)	47 867	6.58	0.22	110.12	17.01	Positive linear		Negative linear
(70, 80)	24 426	6.87	0.48	108.39	16.59	121.50	3.99	98.90	2.08
Race
White	84 028	6.78	0.31	118.30	18.36	Positive linear		Negative linear
Black	24 817	7.11	0.29	104.70	6.27	119.30	5.82	Negative linear
Others	4673	9.94	1.19	Negative linear		Positive linear		Negative linear
BMI
<25	30 084	6.69	0.33	106.95	11.61	Positive linear		Negative linear
(25, 30)	24 989	6.85	0.23	110.50	12.96	Positive linear		Negative linear
≥30	69 578	6.86	0.37	109.2	11.63	Positive linear		Negative linear

BMI, body mass index; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure.